Clinical Trials Directory

Trials / Unknown

UnknownNCT04586361

Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Kaohsiung Veterans General Hospital. · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Purpose: The purpose of this article is to examine the clinical application of PRP and PRP+hyaluronic acid in disorders in the knee. Methods: The study was conducted on 150 adult patients with age over 20 years old affected by unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in three groups, and we treated the group A with perioperative injection of HHA, group B with perioperative HHA+PRP, group C with perioperative normal saline. Follow-up: Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTRegenLab PRPPRP preparations also improved functional outcome scores compared to hyaluronic acid and placebo in patients affected by knee osteoarthritis (OA). Based on previous studys, we can conclude that the PRP treatment is a safe and efficacious procedure which can provide functional benefit.
COMBINATION_PRODUCThyaluronic acidFew studies investigated the effects of HA+PRP combined treatment for knee osteoarthritis (OA). Numerous studies demonstrated the efficacy of HA injection therapy in knee OA for a clinical point of view, reducing the pain and improving the quality of life.
OTHERnormal salineIn this study, we compare introperative PRP/PRP+HA/normal saline in ACL reconstruction patient.

Timeline

Start date
2020-10-15
Primary completion
2021-09-15
Completion
2022-09-15
First posted
2020-10-14
Last updated
2020-10-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04586361. Inclusion in this directory is not an endorsement.